AEZS
Closed
Aeterna Zentaris Inc
4.
+4 (0%)
Last Update: 06 Sep 2024 16:30:00
Yesterday: 0.
Day's Range: 3.7671 - 4.
Send
sign up or login to leave a comment!
When Written:
2.59
Aeterna Zentaris Inc. is a biopharmaceutical company that focuses on developing and commercializing novel treatments in oncology, endocrinology and women's health. The company is headquartered in Charleston, South Carolina, and has operations in Canada and Europe. Aeterna Zentaris' lead product is Macrilen, a diagnostic test for adult growth hormone deficiency. The company is also developing treatments for various cancers, including endometrial and prostate cancers. Aeterna Zentaris was founded in 1991 and is publicly traded on the NASDAQ and TSX exchanges.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








